Streetbeat News

Analyst Ratings

FDX

Raymond James analyst Patrick Tyler Brown maintains an Outperform rating on FedEx (NYSE:FDX) and raises the price target from $270 to $279.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 11:17 am

CLNN

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on Clene (NASDAQ:CLNN) and maintained a $7 price target.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 11:13 am

APLD

HC Wainwright & Co. analyst Kevin Dede has reiterated a 'Buy' rating on Applied Digital (NASDAQ:APLD) and maintained a $12 price target.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 11:08 am

ATLX

HC Wainwright & Co. analyst Heiko Ihle maintains a 'Buy' rating on Atlas Lithium (NASDAQ:ATLX), but has lowered the price target from $56 to $52.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 10:58 am

BSX

Needham analyst Mike Matson maintains a 'Buy' rating on Boston Scientific (NYSE:BSX) and raises the price target from $61 to $65.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 10:37 am

GNFT

HC Wainwright & Co. analyst Ed Arce has reiterated a 'Buy' rating on Genfit (NASDAQ:GNFT) and maintained an $11 price target.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 10:32 am

RGLS

HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a 'Buy' rating on Regulus Therapeutics (NASDAQ:RGLS) and maintained a $9 price target.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 10:29 am

LIFE

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a Buy rating on aTyr Pharma (NASDAQ:LIFE) and maintained a $35 price target.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 10:22 am

ELYS

HC Wainwright & Co. analyst Scott Buck has reiterated a 'Buy' rating on Elys Game Technology (NASDAQ:ELYS) and maintained a $2 price target.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 10:20 am

FDX

Citigroup analyst Christian Wetherbee maintains a Buy rating on FedEx (NYSE:FDX) and raises the price target from $295 to $300.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 10:04 am